Tianjin Chase Sun Pharmaceutical Co Ltd (300026) — Long-term Investment Intensity
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Long-term Investment Intensity of 3.6% as of September 2019. Long-term investments of CN¥303.03 Million represent 3.6% of total assets of CN¥8.31 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 300026 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Tianjin Chase Sun Pharmaceutical Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Tianjin Chase Sun Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 3.6%, reflecting long-term investments of CN¥303.03 Million against total assets of CN¥8.31 Billion CNY. For the complete balance sheet picture, see 300026 current and non-current assets.
Annual Long-term Investment Intensity for Tianjin Chase Sun Pharmaceutical Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Tianjin Chase Sun Pharmaceutical Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read total liabilities of Tianjin Chase Sun Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 3.8% | CN¥281.52 Million | CN¥7.48 Billion | ▲ +0.1 pp |
| 2017 | 3.7% | CN¥273.62 Million | CN¥7.43 Billion | ▲ +0.4 pp |
| 2016 | 3.2% | CN¥235.55 Million | CN¥7.28 Billion | ▲ +2.6 pp |
| 2015 | 0.7% | CN¥43.16 Million | CN¥6.47 Billion | — |